Clinical Advances in Obsessive Compulsive Disorder: A Position Statement by the International College of Obsessive Compulsive Spectrum Disorders
Author
Fineberg, Naomi
Hollander, Eric
Pallanti, Stefano
Walitza, Susanne
Grünblatt, Edna
Dell'Osso, Bernardo
Albert, Umberto
Geller, Daniel
Brakoulias, Vlasios
Reddy, Janardhan Y C
Arumugham, Shyam Sundar
Shavitt, Roseli G.
Drummond, Lynne
Grancini, Benedetta
De Carlo, Vera
Cinosi, Eduardo
Chamberlain, Samuel R.
Ioannidis, Konstantinos
Rodriguez, Carolyn
Garg, Kabir
Castle, David
Van Ameringen, Michael
Stein, Dan J.
Carmi, Lior
Zohar, Joseph
Menchon Magrina, Jose
Attention
2299/22946
Abstract
In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.